Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine phosphate for severe COVID-19 pneumonia
ChiCTR2000029988Phase 4Recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of chloroquine in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia (2 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoint: Time to clinical recovery. Started Feb 2020; status: recruiting.
02
Drugs
chloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on ChiCTR2000029988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029988.